Healthcare Intelligence Desk

Medical Affairs Outsourcing Industry Manufacturer Analysis

Lehdistötiedote   •   Helmi 07, 2020 09:51 EET

Some of the key manufacturing companies include in the global medical affairs outsourcing market are ICON plc, IQVIA Holdings Inc., The Medical Affairs Company (TMAC), Syneos Health Inc., Pharmaceutical Product Development, LLC., Ashfield Healthcare Communications, ZEINCRO Group, Wuxi Clinical Development, Inc., SGS SA, and Indegene Inc.

Get Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1714

Some of the key observations regarding global medical affairs outsourcing industry include:

  • Parexel International Corporation acquired The Medical Affairs Company in 2017. This acquisition has strengthened the commercialization and medical affairs service offering of the company.
  • In May 2017, Rich Pharma, Inc., a developer of oncology therapies, selected IND 2 Results, LLC as a CRO to provide protocol development, medical writing, and regulatory consulting services for its clinical trials on treatment of Hodgkin's Lymphoma and Acute Myelocytic Leukemia.
  • In April 2019, Charles River Laboratories International, Inc. acquired Citoxlab, a non-clinical Contract Research Organization (CRO) offering regulated safety assessment services, medical device testing, and other services. The acquisition has expanded Charles' offerings and strengthened its market position as a CRO.

The global medical affairs outsourcing market size is poised to reach around US$ 2.65 billion by 2026.

The medical affairs outsourcing market is anticipated to grow at a CAGR of around 10.6% during the forecast period 2019 to 2026.

North America dominated the global medical affairs outsourcing market in the year 2018. Different huge purposes behind the predominance of North America are the presence of worldwide pharmaceutical and life sciences firms, robust regulators like fda and therefore the accessibility of talent pool can contribute to the overall growth. However, high service value compared to the Asia Pacific and geographical area may be a major challenge moving the regional growth. The growing numbers of patent expirations with increasing expenditure of R&D activities are the most necessary factors influencing the event of the world regulatory affairs outsourcing market. Biopharmaceutical and health care organizations are projected to team with many outsourcing companies to get their devices and medicines approved within the international market. The authorization time of a tool or drug is taken into account to belong, costly, as well as it is also a documentation-centric technique. There's an increased requirement for skilled service suppliers that primarily specialize in knowledge handling that is expounded to regulative affairs so additional increasing the need for reliable service givers for regulatory affairs outsourcing. In addition, because the medical sector is experiencing a high rate of product innovations from many corporations vying to form a mark during this extremely competitive market, expenditure on R&D is additionally growing. during this regard, expenditure pressures and extreme competition are seemingly to push many corporations to find out new ways in which to cut down the expenditure, thus outsourcing is gradually being more most well-liked over in-house data administration because it is regarded to be cheaper likewise as resource-efficient thanks to managing large quantity of information generated throughout approvals, clinical trials, and patent approvals. The pharmaceutical and medical device companies are outsourcing their medical affairs services in order to diverge their business activities and manage product life cycles. Additionally, contract analysis organizations offer cost-efficient solutions and compliance with the health authority necessities, thereby propelling the market growth.

Asia- Pacific is expected to register the highest CAGR during the forecast period. The availability of low-cost labor and rising cases of regulatory filings are the factors dynamic the regional growth. The growth of multi-national life science and pharmaceutical companies is additionally projected to foster regional demand.

Medical Science Liaisonshas dominated the offering segment in the year 2018 and the segment is projected to maintain its dominance over the forecast period.Medical science Liaisons (MSLs) are medical specialists with advanced scientific training. they're specialists in communicating complex medical info to a range of stakeholders. As MSLs are majorly needed when launch of the merchandise, it's not efficient for pharmaceutical or medical devices firms to stay MSLs on workers. Also, to overcome insufficient and non-uniform training, pharmaceutical & medical devices firms are expected to majorly source these MSLs activities to contract analysis organizations over forecast amount.

The Medical affairs outsourcing market is divided as pharmaceutical, biopharmaceutical, and medical devices. The pharmaceutical sector held the biggest market share, accounting for 53.2% in 2018 due to surge in patent expiration. because of various patent expiration, the necessity of medical affairs service suppliers has increased for the preparation of drafts of new patents.

The biopharma business is growing at a high rate and captured over 25% of the total pharmaceutical market. The biopharma business is focusing on the core activities related to drug development compared to the non-core activities such as medical affairs. to reduce expenditure and avail skilled medical affairs services, biopharma companies are outsourcing these services to the contract analysis organizations.

Market Segmentation

Market By Services

  • Medical Writing & Publishing
  • Medical Monitoring
  • Medical Science Liaisons
  • Medical Information

Market By End User

  • Mid- Sized Pharmaceutical Companies
  • Biotechnology Companies
  • Others

Market By Application

  • Pharma and Biotech Products
  • Medical Devices
  • Others

Market By Geography

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Medical Affairs Outsourcing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Medical Affairs Outsourcing Market By Services
1.2.2.1. Global Medical Affairs Outsourcing Market Revenue and Growth Rate Comparison By Services(2015-2026)
1.2.2.2. Global Medical Affairs Outsourcing Market Revenue Share By Services in 2018
1.2.2.3. Medical Writings & Publishing
1.2.2.4. Medical Monitoring
1.2.2.5. Medical Science Liaisons
1.2.2.6. Medical Information
1.2.3. Medical Affairs Outsourcing Market By End User
1.2.3.1. Global Medical Affairs Outsourcing Market Revenue and Growth Rate Comparison By End User (2015-2026)
1.2.3.2. Global Medical Affairs Outsourcing Market Revenue Share By End User in 2018
1.2.3.3. Mid-Sized Pharmaceutical Companies
1.2.3.4. Biotechnology Companies
1.2.4. Medical Affairs Outsourcing Market By Application
1.2.4.1. Global Medical Affairs Outsourcing Market Revenue and Growth Rate Comparison By Application(2015-2026)
1.2.4.2. Global Medical Affairs Outsourcing Market Revenue Share By Application in 2018
1.2.4.3. Pharma and Biotech Products
1.2.4.4. Medical Devices
1.2.5. Medical Affairs Outsourcing Market by Geography
1.2.5.1. Global Medical Affairs Outsourcing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Medical Affairs Outsourcing Market Revenue and Growth Rate(2015-2026)
1.2.5.3. Europe Medical Affairs Outsourcing Market Revenue and Growth Rate(2015-2026)
1.2.5.4. Asia-Pacific Medical Affairs Outsourcing Market Revenue and Growth Rate(2015-2026)
1.2.5.5. Latin America Medical Affairs Outsourcing Market Revenue and Growth Rate(2015-2026)
1.2.5.6. Middle East and Africa (MEA)Medical Affairs Outsourcing Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING MEDICAL AFFAIRS OUTSOURCING ANALYSIS
3.1. Capacity and Commercial Production Date of Global Medical Affairs Outsourcing Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Medical Affairs Outsourcing Major Manufacturers in 2018
3.3. R&D Status and Services End-User of Global Medical Affairs Outsourcing Major Manufacturers in 2018
3.4. Raw Materials End-Users Analysis of Global Medical Affairs Outsourcing Major Manufacturers in 2018

CHAPTER 4. MEDICAL AFFAIRS OUTSOURCING MARKET BY SERVICES
4.1. Global Medical Affairs Outsourcing Revenue By Services
4.2. Medical Writings & Publishing
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Medical Monitoring
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Medical Science Liaisons
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Medical Information
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. MEDICAL AFFAIRS OUTSOURCING MARKET BY END USER
5.1. Global Medical Affairs Outsourcing Revenue By End User
5.2. Mid- Sized Pharmaceutical Companies
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Biotechnology Companies
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. MEDICAL AFFAIRS OUTSOURCING MARKET BY APPLICATION
6.1. Global Medical Affairs Outsourcing Revenue By Application
6.2. Pharma and Biotech Products
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Medical Devices
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET BY COUNTRY
7.1. North America Medical Affairs Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Medical Affairs Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Medical Affairs Outsourcing Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET BY COUNTRY
8.1. Europe Medical Affairs Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Medical Affairs Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET BY COUNTRY
9.1. Asia-Pacific Medical Affairs Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Medical Affairs Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET BY COUNTRY
10.1. Latin America Medical Affairs Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Medical Affairs Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET BY COUNTRY
11.1. Middle East & Africa Medical Affairs Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Medical Affairs Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Services, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. ICON plc
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Services Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. IQVIA HoldingsInc
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Services Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. The Medical Affairs Company(TMAC)
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Services Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Syneos Health Inc.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Services Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Pharmaceutical Product Development, LLC.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Services Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Ashfield Healthcare Communications
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Services Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. ZEINCRO Group
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Services Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Wuxi Clinical Development Inc.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Services Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. IndegeneInc
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Services Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Others
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Services Portfolio
12.10.5. Key Developments
12.10.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research

13.2. Assumptions and Scope